Methylprednisolone Sodium recalls
The FDA has published 4 recalls involving Methylprednisolone Sodium since 2018. The latest was reported on 29 Jan 2020. Most were for potency & assay. Sagent Pharmaceuticals has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls4since 2018
Last 12 months0reported
Class I00% of total
Ongoing0latest 29 Jan 2020
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 3 75%Class III 1 25%
Why methylprednisolone sodium is recalled
Companies
By year
All methylprednisolone sodium recalls, newest first
4 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | methylPREDNISolone Sodium Succinate For Injection, USP, 500 mg*/vial recalledMethylprednisolone Sodium Succinate | Hikma Pharmaceuticals USA | Other | Nationwide |
| Drug | CLASS II | methylPREDNISolone Sodium Succinate for Injection recalled | Sagent Pharmaceuticals | Potency & Assay | Nationwide |
| Drug | CLASS II | methylPREDNISolone Sodium Succinate for Injection recalled | Sagent Pharmaceuticals | Potency & Assay | Nationwide |
| Drug | CLASS II | methylPREDNISolone Sodium Succinate for Injection recalled | Sagent Pharmaceuticals | Potency & Assay | Nationwide |
Should you stop taking Methylprednisolone Sodium?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.